Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine

American Journal of Pathology

Volumn 157, Issue 5, 2000, Pages 1511-1522

  Renzi, Daniela ^a   Pellegrini, Beatrice ^a   Tonelli, Francesco ^a   Surrenti, Calogero ^a   Calabro, Antonio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ A; SUBSTANCE P;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; RECEPTOR DENSITY; RECEPTOR GENE; ULCERATIVE COLITIS;

EID: 0033678445     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64789-X     Document Type: Article

References (55)

1. Neurotransmitter functions of mammalians tachykinins
2. Tachykinins in the gut. Part I. Expression, release and motor function
3. Enterochromaffin cells as the endocrine source of gastrointestinal substance P
4. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide
5. Substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats
6. Conversion of neuropeptide K to neurokinin A and vesicular colocalization of neurokinin A and substance P in neurons of the guinea-pig small intestine
7. Intestinal peristalsis associated with release of substance P
8. Molecular characterization of rat substance K receptor and its mRNAs
9. Molecular characterization of a functional cDNA encoding the rat substance P receptor
10. The primary structure and gene organization of human substance P and neuromedin K receptors
11. Mammatian tachykinin receptors
12. Tachykinin receptor types: Classification and membrane signalling mechanisms
13. Receptors and antagonists for substance P and related peptides
14. The mammalian tachykinin receptors
15. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation
16. Immunomodulation by tachykinin neuropeptides
17. Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflammation
18. The effect of tachykinins on inflammatory and immune cells
19. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease
20. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease
21. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis
22. Interactions between neutral endopeptidase (EC 3.4.24.11) and the substance P (NK1) receptor expressed in mammalian cells
23. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver
24. Expression of epidermal growth factor, transforming growth factor-α and their receptor in the human oesophagus
25. Polyclonal antibodies against the rat NK1 receptor: Characterization and localization in the spinal cord
26. Receptor binding sites for substance P and substance K in the canine gastrointestinal tract and their possible role in inflammatory bowel disease
27. Substance P and substance K receptor binding sites in the human gastrointestinal tract: Localization by autoradiography
28. Distribution of vasoactive intestinal polypeptide and substance P receptors in human colon and small intestine
29. Tachykinin receptors and intestinal motility
30. Cellular sites of expression of the neurokinin-1 receptor in the rat gastrointestinal tract
31. 1 receptor immunoreactivity to neurons and interstitial cells of the guinea-pig gastrointestinal tract
32. Substance P produces sodium and bicarbonate secretion in porcine jejunal mucosa through an action on enteric neurons
33. Effects of substance P on human colonic mucosa in vitro
34. Different substance P receptors are found on mucosal epithelial cells and submucous neurons of the guinea-pig small intestine
35. Epithelial and mucosal preparation from canine colon: Responses to substance P
36. Substance P as a mediator of colonic secretory reflexes
37. Substance P (Neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: Molecular quantitation and localization
38. Functional subtyping of neurokinin receptors on canine proximal colonic mucosa
39. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration
40. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells
41. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P
42. Induction of endothelial cell differentiation into capillary-like structures by substance P
43. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
44. Effects of substance P and selected other neuropeptides on the synthesis of interleukin 1b and interleukin-6 in human monocytes: A re-examination
45. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin
46. Beneficial effects of local or systemic lidocaine in experimental colitis
47. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum
48. CP-96345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin
49. Substance P receptor expression in intestinal epithelium in Clostridium difficile toxin A enteritis in rats
50. Neurokinin-1 (NK-1) receptor is required in Clostridlum difficile-induced enteritis
51. Immunoregulatory effect of substance P in human eosinophil migratory function
52. Mechanisms involved in activation of human eosinophils exocytosis by substance P: An in vitro model of sensory neuroimmunomodulation